by AI in Medical Imaging Market Size in 2026
The global AI in Medical Imaging Market is experiencing exponential growth, projected to reach approximately USD 20.5 billion by 2034, expanding at a robust CAGR of 28.7% from 2025 to 2034. The surge is primarily fueled by increasing demand for early and accurate disease diagnosis, rising imaging data volumes, and growing integration of artificial intelligence into radiology workflows.
Healthcare providers worldwide are rapidly embracing AI-powered imaging solutions to enhance diagnostic precision, reduce turnaround times, and optimize clinical decision-making. Additionally, the growing burden of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions continues to accelerate the adoption of AI-driven imaging technologies.
What’s Powering the Market?
The market was valued at USD 2.1 billion in 2024, showcasing strong early-stage growth momentum.
North America leads the global market, driven by advanced healthcare infrastructure and early AI adoption.
Deep learning technology dominates, owing to its superior image recognition capabilities.
Hospitals remain the largest end-user segment, supported by increasing imaging volumes.
Key players include GE Healthcare, Siemens Healthineers, Philips Healthcare, IBM, and Canon Medical Systems, among others.
How Is AI Transforming Medical Imaging Today?
Artificial intelligence is redefining medical imaging by enabling faster and more accurate detection of anomalies in radiology scans such as X-rays, MRIs, and CT scans. AI algorithms assist radiologists in identifying subtle patterns that may be missed during manual analysis, significantly improving diagnostic outcomes.
Furthermore, AI enhances workflow efficiency by automating repetitive tasks such as image segmentation, prioritization of critical cases, and report generation. This reduces physician burnout and allows clinicians to focus more on patient care rather than administrative workloads.
Market Dynamics: What’s Driving Growth?
Why Is Demand for AI in Imaging Accelerating?
The rising prevalence of chronic diseases and the need for early diagnosis are key drivers of market expansion. AI tools enable quicker detection of tumors, fractures, and neurological abnormalities, improving patient survival rates.
How Is Data Explosion Influencing Adoption?
The exponential growth in imaging data has created a pressing need for advanced analytics. AI-powered platforms help healthcare providers efficiently process and interpret large datasets, ensuring timely diagnosis.
What Role Does Government Support Play?
Favorable regulatory frameworks and increasing investments in digital healthcare infrastructure are accelerating AI adoption across developed and emerging economies.
What Opportunities and Trends Are Shaping the Future?
Is AI Integration in Radiology the Next Big Leap?
Yes, seamless integration of AI into radiology systems is expected to revolutionize diagnostic workflows, making imaging faster and more efficient.
Will Cloud-Based AI Solutions Dominate?
Cloud deployment is gaining traction due to scalability, cost-effectiveness, and remote accessibility, especially in emerging markets.
Can AI Enable Personalized Medicine?
AI-driven imaging insights are paving the way for personalized treatment plans, particularly in oncology and cardiology.
Segmental Insights
Clinical Area Insights
The lung and pulmonary segment held the largest share of the AI in medical imaging market in 2025, accounting for 22%. This leadership is mainly due to the high number of chest imaging procedures performed globally. The growing incidence of respiratory diseases such as pneumonia, COPD, and tuberculosis has significantly increased the need for AI-powered diagnostic tools.
Within this segment, non-cancerous lung conditions contributed the most, as AI helps clinicians detect diseases earlier and make better treatment decisions. The widespread use of chest X-rays and CT scans has further strengthened this segment’s dominance.
Among all clinical areas, oncology is expected to grow the fastest in the coming years. This growth is driven by the rising global burden of cancer and the increasing demand for early and accurate diagnosis. AI is being widely used for tumor detection, segmentation, and monitoring treatment progress. Advances in precision medicine and personalized cancer care are also accelerating adoption.
Technology Type Insights
Deep learning technologies led the market in 2025, with convolutional neural networks (CNNs) alone accounting for 48% of the share. CNNs are highly effective in analyzing medical images, making them ideal for tasks like detection, classification, and segmentation.
Because of their accuracy and reliability, CNNs have become the backbone of most AI imaging applications.
Looking ahead, explainable AI (XAI) is expected to grow the fastest. As healthcare professionals increasingly demand transparency, XAI helps them understand how AI systems arrive at decisions. This improves trust and usability, while also aligning with regulatory requirements for ethical and accountable AI.
Deployment Mode Insights
On-premise deployment dominated the market in 2025, capturing 58% of the share. Hospitals prefer this model because it offers better control over sensitive patient data and ensures compliance with strict data security regulations. It also integrates more easily with existing hospital IT systems.
However, edge or embedded AI is expected to grow at the fastest rate. This approach enables real-time image processing directly on devices, reducing delays. It is especially useful in emergency and critical care situations where quick decisions are crucial.
Imaging Modality Insights
CT scans held the largest market share in 2025 at 37%. Their widespread use in diagnosing lung conditions, cancer, and trauma cases generates a high volume of imaging data. AI enhances CT imaging by improving detection accuracy and streamlining workflows.
Meanwhile, MRI is projected to grow the fastest. Its increasing use in neurology, oncology, and musculoskeletal imaging is driving demand. AI integration in MRI improves image quality, reduces scan time, and enhances diagnostic precision, making it increasingly valuable in clinical practice.
Functionality Insights
Image analysis was the leading functionality segment in 2025, accounting for 51% of the market. It plays a central role in AI-powered imaging by helping detect, segment, and measure abnormalities.
Healthcare providers are increasingly relying on automated image analysis to reduce workload and improve accuracy, making it the most widely adopted application.
Product Type Insights
Software solutions dominated the market in 2025, with a 77% share. They are easy to integrate into existing imaging systems and offer flexibility, scalability, and regular updates without requiring major hardware changes.
On the other hand, AI-enabled hardware is expected to see significant growth. The integration of AI processors into imaging devices allows for faster, real-time analysis. Continued advancements in smart imaging equipment are supporting this trend.
End User Insights
Hospitals were the largest end users in 2025, holding 65% of the market share. Their high patient volumes, advanced infrastructure, and strong financial capacity enable early adoption of AI technologies. These institutions use AI to improve diagnostic accuracy and operational efficiency.
Diagnostic imaging centers are expected to grow the fastest. Increasing demand for specialized and outpatient imaging services is driving this growth. These centers are adopting AI to speed up workflows and deliver faster results, especially in a competitive market.
Regional Insights
North America led the global AI in medical imaging market in 2025, accounting for 45% of the total share. This dominance is supported by the presence of major industry players, strong government support, and widespread adoption of advanced technologies. The United States and Canada are expected to remain key contributors to market growth.
The Asia Pacific region is projected to grow the fastest. Factors such as rising healthcare demand, rapid technological advancements, and supportive government policies are driving this growth. Countries like India, China, and Australia are actively using AI to improve diagnostic accuracy and efficiency.
In India, the adoption of AI in medical imaging is accelerating due to a strong health-tech ecosystem and government initiatives like the Ayushman Bharat Digital Mission. Startups such as Qure.ai and Niramai are playing a key role in developing AI-based diagnostic tools, improving early disease detection, and expanding access to healthcare.
Europe is also expected to see steady growth, supported by strong healthcare systems and collaborative research efforts. Countries like Germany, the UK, and Spain are leading AI adoption in medical imaging. For example, the UK’s National Health Service is implementing AI to enhance diagnostic accuracy, while Germany focuses on partnerships between healthcare providers and technology firms.
South America is emerging as a promising market, driven by increasing healthcare digitization and the need to improve diagnostic capabilities. Investments in imaging infrastructure and AI solutions are helping address radiologist shortages and improve early disease detection. Brazil, in particular, stands out due to its large healthcare system and growing adoption of AI tools.
The Middle East and Africa region is gradually expanding, supported by healthcare modernization efforts and rising investments in digital health. While adoption is still developing in many African countries, AI is helping improve access to diagnostic services. South Africa is a key market in this region, leveraging AI to address workforce shortages and enhance diagnostic efficiency.
AI in Medical Imaging Market Companies
- Agfa-Gevaert Group
- Ada Health
- Enlitic Inc
- CELLMATIQ GMBH
- GENERAL ELECTRIC COMPANY
- IBM
- NVIDIA CORPORATION
- MICROSOFT
- KONINKLIJKE PHILIPS N.V.
- SIEMENS
Segment Covered in the Report
By Clinical Area
- Lung/Pulmonary
- Lung cancer
- Non-cancer lung diseases
- Brain/Neurology
- Stroke/Haemorrhage
- Dementia & Neurodegenerative Diseases
- Brain Tumors/Lesions
- Heart/Cardiology
- Coronary Artery Diseases
- Heart Failure & Functional Assessment
- Congenital & Structural Heart Diseases
- Oncology
- Musculoskeletal
- Gastroenterology/Hepatology
- Ophthalmology
- Other Specialities (Obstetrics/Gynaecology, Urology, Dermatology)
By Technology Type
- Machine Learning
- Deep Learning
- CNN
- RNN/LSTM
- Transformers/ViTs
- Generative Models (GANs, Diffusers)
- Natural Language Processing (NLP)
- Hybrid/ Multimodal AI
- Explainable AI (XAI)
By Deployment Type
- On-premise
- Cloud-based
- Hybrid
- Edge/Embedded
By Imaging Modality
- X-ray
- CT Scan
- MRI
- Ultrasound
- PET/SPECT
- Other Imaging Modalities
By Functionality
- Image Acquisition & Reconstruction
- Image Enhancement &Processing
- Image Analysis
- Segmentation
- Detection
- Classification
- Quantification
- Workflow & Reporting
- Predictive & Prognostic Analytics
By Product Type
- Software
- AI Analysis Software
- AI Workflow & Reporting Tools
- AI-enabled Hardware
- Imaging Device with Embedded AI (CT, MRI, X-ray, Ultrasound)
- Edge/AI Workstations
- AI Accelerators
By End User
- Hospitals
- Diagnostic Imaging Centers
- Research & Academic Institutes
By Geography
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa (MEA)
Get Sample : https://www.precedenceresearch.com/sample/2380
Also Read : https://www.expresswebwire.com/digital-health-market-2/
